Report Detail

Machinery & Equipment Global Multi-Material 3D Bioprinting Market Growth (Status and Outlook) 2023-2029

  • RnM4500970
  • |
  • 09 January, 2023
  • |
  • Global
  • |
  • 110 Pages
  • |
  • LPI(LP Information)
  • |
  • Machinery & Equipment

Newest research report, the “Multi-Material 3D Bioprinting Industry Forecast” looks at past sales and reviews total world Multi-Material 3D Bioprinting sales in 2022, providing a comprehensive analysis by region and market sector of projected Multi-Material 3D Bioprinting sales for 2023 through 2029. With Multi-Material 3D Bioprinting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi-Material 3D Bioprinting industry.

This Insight Report provides a comprehensive analysis of the global Multi-Material 3D Bioprinting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi-Material 3D Bioprinting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi-Material 3D Bioprinting market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi-Material 3D Bioprinting and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi-Material 3D Bioprinting.

The global Multi-Material 3D Bioprinting market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Multi-Material 3D Bioprinting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Multi-Material 3D Bioprinting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Multi-Material 3D Bioprinting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Multi-Material 3D Bioprinting players cover Organovo, CELLINK, Aspect Biosystem, Cyfuse Biomedical, TeVido Biodevices, Digilab, Advanced Solutions Life Sciences, Tissue Regeneration Systems and nScrypt, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Multi-Material 3D Bioprinting market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Extrusion-based Bioprinting
Inkjet-based Bioprinting
Laser-assisted Bioprinting
Others

Segmentation by application
Pharmaceutical
Research Institutions
Medical Device
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Organovo
CELLINK
Aspect Biosystem
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
Tissue Regeneration Systems
nScrypt
EnvisionTEC
MedPrin
Nano3D Sciences (n3D)
Rokit
Cellbricks
REGEMAT 3D
Allevi
Poietis


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Multi-Material 3D Bioprinting Market Size 2018-2029
    • 2.1.2 Multi-Material 3D Bioprinting Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 Multi-Material 3D Bioprinting Segment by Type
    • 2.2.1 Extrusion-based Bioprinting
    • 2.2.2 Inkjet-based Bioprinting
    • 2.2.3 Laser-assisted Bioprinting
    • 2.2.4 Others
  • 2.3 Multi-Material 3D Bioprinting Market Size by Type
    • 2.3.1 Multi-Material 3D Bioprinting Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global Multi-Material 3D Bioprinting Market Size Market Share by Type (2018-2023)
  • 2.4 Multi-Material 3D Bioprinting Segment by Application
    • 2.4.1 Pharmaceutical
    • 2.4.2 Research Institutions
    • 2.4.3 Medical Device
    • 2.4.4 Others
  • 2.5 Multi-Material 3D Bioprinting Market Size by Application
    • 2.5.1 Multi-Material 3D Bioprinting Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global Multi-Material 3D Bioprinting Market Size Market Share by Application (2018-2023)

3 Multi-Material 3D Bioprinting Market Size by Player

  • 3.1 Multi-Material 3D Bioprinting Market Size Market Share by Players
    • 3.1.1 Global Multi-Material 3D Bioprinting Revenue by Players (2018-2023)
    • 3.1.2 Global Multi-Material 3D Bioprinting Revenue Market Share by Players (2018-2023)
  • 3.2 Global Multi-Material 3D Bioprinting Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Multi-Material 3D Bioprinting by Regions

  • 4.1 Multi-Material 3D Bioprinting Market Size by Regions (2018-2023)
  • 4.2 Americas Multi-Material 3D Bioprinting Market Size Growth (2018-2023)
  • 4.3 APAC Multi-Material 3D Bioprinting Market Size Growth (2018-2023)
  • 4.4 Europe Multi-Material 3D Bioprinting Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa Multi-Material 3D Bioprinting Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas Multi-Material 3D Bioprinting Market Size by Country (2018-2023)
  • 5.2 Americas Multi-Material 3D Bioprinting Market Size by Type (2018-2023)
  • 5.3 Americas Multi-Material 3D Bioprinting Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Multi-Material 3D Bioprinting Market Size by Region (2018-2023)
  • 6.2 APAC Multi-Material 3D Bioprinting Market Size by Type (2018-2023)
  • 6.3 APAC Multi-Material 3D Bioprinting Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Multi-Material 3D Bioprinting by Country (2018-2023)
  • 7.2 Europe Multi-Material 3D Bioprinting Market Size by Type (2018-2023)
  • 7.3 Europe Multi-Material 3D Bioprinting Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Multi-Material 3D Bioprinting by Region (2018-2023)
  • 8.2 Middle East & Africa Multi-Material 3D Bioprinting Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa Multi-Material 3D Bioprinting Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Multi-Material 3D Bioprinting Market Forecast

  • 10.1 Global Multi-Material 3D Bioprinting Forecast by Regions (2024-2029)
    • 10.1.1 Global Multi-Material 3D Bioprinting Forecast by Regions (2024-2029)
    • 10.1.2 Americas Multi-Material 3D Bioprinting Forecast
    • 10.1.3 APAC Multi-Material 3D Bioprinting Forecast
    • 10.1.4 Europe Multi-Material 3D Bioprinting Forecast
    • 10.1.5 Middle East & Africa Multi-Material 3D Bioprinting Forecast
  • 10.2 Americas Multi-Material 3D Bioprinting Forecast by Country (2024-2029)
    • 10.2.1 United States Multi-Material 3D Bioprinting Market Forecast
    • 10.2.2 Canada Multi-Material 3D Bioprinting Market Forecast
    • 10.2.3 Mexico Multi-Material 3D Bioprinting Market Forecast
    • 10.2.4 Brazil Multi-Material 3D Bioprinting Market Forecast
  • 10.3 APAC Multi-Material 3D Bioprinting Forecast by Region (2024-2029)
    • 10.3.1 China Multi-Material 3D Bioprinting Market Forecast
    • 10.3.2 Japan Multi-Material 3D Bioprinting Market Forecast
    • 10.3.3 Korea Multi-Material 3D Bioprinting Market Forecast
    • 10.3.4 Southeast Asia Multi-Material 3D Bioprinting Market Forecast
    • 10.3.5 India Multi-Material 3D Bioprinting Market Forecast
    • 10.3.6 Australia Multi-Material 3D Bioprinting Market Forecast
  • 10.4 Europe Multi-Material 3D Bioprinting Forecast by Country (2024-2029)
    • 10.4.1 Germany Multi-Material 3D Bioprinting Market Forecast
    • 10.4.2 France Multi-Material 3D Bioprinting Market Forecast
    • 10.4.3 UK Multi-Material 3D Bioprinting Market Forecast
    • 10.4.4 Italy Multi-Material 3D Bioprinting Market Forecast
    • 10.4.5 Russia Multi-Material 3D Bioprinting Market Forecast
  • 10.5 Middle East & Africa Multi-Material 3D Bioprinting Forecast by Region (2024-2029)
    • 10.5.1 Egypt Multi-Material 3D Bioprinting Market Forecast
    • 10.5.2 South Africa Multi-Material 3D Bioprinting Market Forecast
    • 10.5.3 Israel Multi-Material 3D Bioprinting Market Forecast
    • 10.5.4 Turkey Multi-Material 3D Bioprinting Market Forecast
    • 10.5.5 GCC Countries Multi-Material 3D Bioprinting Market Forecast
  • 10.6 Global Multi-Material 3D Bioprinting Forecast by Type (2024-2029)
  • 10.7 Global Multi-Material 3D Bioprinting Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Organovo
    • 11.1.1 Organovo Company Information
    • 11.1.2 Organovo Multi-Material 3D Bioprinting Product Offered
    • 11.1.3 Organovo Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Organovo Main Business Overview
    • 11.1.5 Organovo Latest Developments
  • 11.2 CELLINK
    • 11.2.1 CELLINK Company Information
    • 11.2.2 CELLINK Multi-Material 3D Bioprinting Product Offered
    • 11.2.3 CELLINK Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 CELLINK Main Business Overview
    • 11.2.5 CELLINK Latest Developments
  • 11.3 Aspect Biosystem
    • 11.3.1 Aspect Biosystem Company Information
    • 11.3.2 Aspect Biosystem Multi-Material 3D Bioprinting Product Offered
    • 11.3.3 Aspect Biosystem Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 Aspect Biosystem Main Business Overview
    • 11.3.5 Aspect Biosystem Latest Developments
  • 11.4 Cyfuse Biomedical
    • 11.4.1 Cyfuse Biomedical Company Information
    • 11.4.2 Cyfuse Biomedical Multi-Material 3D Bioprinting Product Offered
    • 11.4.3 Cyfuse Biomedical Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Cyfuse Biomedical Main Business Overview
    • 11.4.5 Cyfuse Biomedical Latest Developments
  • 11.5 TeVido Biodevices
    • 11.5.1 TeVido Biodevices Company Information
    • 11.5.2 TeVido Biodevices Multi-Material 3D Bioprinting Product Offered
    • 11.5.3 TeVido Biodevices Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 TeVido Biodevices Main Business Overview
    • 11.5.5 TeVido Biodevices Latest Developments
  • 11.6 Digilab
    • 11.6.1 Digilab Company Information
    • 11.6.2 Digilab Multi-Material 3D Bioprinting Product Offered
    • 11.6.3 Digilab Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 Digilab Main Business Overview
    • 11.6.5 Digilab Latest Developments
  • 11.7 Advanced Solutions Life Sciences
    • 11.7.1 Advanced Solutions Life Sciences Company Information
    • 11.7.2 Advanced Solutions Life Sciences Multi-Material 3D Bioprinting Product Offered
    • 11.7.3 Advanced Solutions Life Sciences Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Advanced Solutions Life Sciences Main Business Overview
    • 11.7.5 Advanced Solutions Life Sciences Latest Developments
  • 11.8 Tissue Regeneration Systems
    • 11.8.1 Tissue Regeneration Systems Company Information
    • 11.8.2 Tissue Regeneration Systems Multi-Material 3D Bioprinting Product Offered
    • 11.8.3 Tissue Regeneration Systems Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Tissue Regeneration Systems Main Business Overview
    • 11.8.5 Tissue Regeneration Systems Latest Developments
  • 11.9 nScrypt
    • 11.9.1 nScrypt Company Information
    • 11.9.2 nScrypt Multi-Material 3D Bioprinting Product Offered
    • 11.9.3 nScrypt Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.9.4 nScrypt Main Business Overview
    • 11.9.5 nScrypt Latest Developments
  • 11.10 EnvisionTEC
    • 11.10.1 EnvisionTEC Company Information
    • 11.10.2 EnvisionTEC Multi-Material 3D Bioprinting Product Offered
    • 11.10.3 EnvisionTEC Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.10.4 EnvisionTEC Main Business Overview
    • 11.10.5 EnvisionTEC Latest Developments
  • 11.11 MedPrin
    • 11.11.1 MedPrin Company Information
    • 11.11.2 MedPrin Multi-Material 3D Bioprinting Product Offered
    • 11.11.3 MedPrin Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.11.4 MedPrin Main Business Overview
    • 11.11.5 MedPrin Latest Developments
  • 11.12 Nano3D Sciences (n3D)
    • 11.12.1 Nano3D Sciences (n3D) Company Information
    • 11.12.2 Nano3D Sciences (n3D) Multi-Material 3D Bioprinting Product Offered
    • 11.12.3 Nano3D Sciences (n3D) Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.12.4 Nano3D Sciences (n3D) Main Business Overview
    • 11.12.5 Nano3D Sciences (n3D) Latest Developments
  • 11.13 Rokit
    • 11.13.1 Rokit Company Information
    • 11.13.2 Rokit Multi-Material 3D Bioprinting Product Offered
    • 11.13.3 Rokit Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.13.4 Rokit Main Business Overview
    • 11.13.5 Rokit Latest Developments
  • 11.14 Cellbricks
    • 11.14.1 Cellbricks Company Information
    • 11.14.2 Cellbricks Multi-Material 3D Bioprinting Product Offered
    • 11.14.3 Cellbricks Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.14.4 Cellbricks Main Business Overview
    • 11.14.5 Cellbricks Latest Developments
  • 11.15 REGEMAT 3D
    • 11.15.1 REGEMAT 3D Company Information
    • 11.15.2 REGEMAT 3D Multi-Material 3D Bioprinting Product Offered
    • 11.15.3 REGEMAT 3D Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.15.4 REGEMAT 3D Main Business Overview
    • 11.15.5 REGEMAT 3D Latest Developments
  • 11.16 Allevi
    • 11.16.1 Allevi Company Information
    • 11.16.2 Allevi Multi-Material 3D Bioprinting Product Offered
    • 11.16.3 Allevi Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.16.4 Allevi Main Business Overview
    • 11.16.5 Allevi Latest Developments
  • 11.17 Poietis
    • 11.17.1 Poietis Company Information
    • 11.17.2 Poietis Multi-Material 3D Bioprinting Product Offered
    • 11.17.3 Poietis Multi-Material 3D Bioprinting Revenue, Gross Margin and Market Share (2018-2023)
    • 11.17.4 Poietis Main Business Overview
    • 11.17.5 Poietis Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Multi-Material 3D Bioprinting. Industry analysis & Market Report on Multi-Material 3D Bioprinting is a syndicated market report, published as Global Multi-Material 3D Bioprinting Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Multi-Material 3D Bioprinting market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,986.56
5,973.12
3,348.90
6,697.80
470,639.40
941,278.80
300,522.60
601,045.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report